ICH works on harmonizing data acceptance from multi-regional drug trials
This article was originally published in SRA
Executive Summary
The International Conference on Harmonisation is working on establishing general principles on how sponsors can plan and design multi-regional clinical trials so as to facilitate the acceptance of data from such studies by multiple regulatory agencies1,2.
You may also be interested in...
Finalized ICH Guide Supports Global Approach To Collecting Genomic Samples, Data During Trials
A new guideline finalized by the International Council for Harmonisation is expected to facilitate global genomic studies by enabling a common understanding of critical underlying parameters.
ICH To Fix Inconsistencies With RCTs, Address Use Of Alternate Designs And Data Sources
The International Council for Harmonisation has proposed major changes to its good clinical practice requirements in a bid to allay concerns about the problems they pose in conducting well-designed randomized trials. The revised GCP framework would also address the increasing diversity of clinical trial designs and data sources.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.